Conduit Pharmaceuticals Inc. (CDTTW) SEC Filings — 2024
30 SEC filings for Conduit Pharmaceuticals Inc. (CDTTW) in 2024.
Filings
- Conduit Pharmaceuticals Faces Nasdaq Delisting — 8-K · Dec 20, 2024
- Conduit Pharmaceuticals Enters Material Agreement, Discloses Equity Sales — 8-K · Dec 17, 2024
- Conduit Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Dec 6, 2024
- Conduit Pharmaceuticals Files 8-K: Agreements, Obligations, and Equity Sales — 8-K · Nov 25, 2024
- Conduit Pharmaceuticals Files 8-K on Corporate Changes — 8-K · Nov 19, 2024
- Conduit Pharmaceuticals Restates Financials — 8-K · Nov 14, 2024
- Conduit Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Nov 6, 2024
- Conduit Pharmaceuticals Reports Material Agreements & Equity Sales — 8-K · Nov 1, 2024
- Conduit Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Oct 28, 2024
- Conduit Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Oct 18, 2024
- Conduit Pharmaceuticals Enters Material Definitive Agreement — 8-K · Oct 15, 2024
- Conduit Pharmaceuticals Inc. SC 13G Filing — SC 13G · Oct 11, 2024
- Conduit Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Oct 7, 2024
- Conduit Pharmaceuticals Inc. SC 13D/A Filing — SC 13D/A · Sep 19, 2024
- Conduit Pharmaceuticals Files S-1/A for IPO — S-1/A · Sep 13, 2024
- Conduit Pharmaceuticals Files 8-K on Shareholder Nominations — 8-K · Sep 6, 2024
- Conduit Pharmaceuticals Inc. Files S-1 — S-1 · Sep 4, 2024
- Conduit Pharmaceuticals Faces Nasdaq Listing Rule Non-Compliance — 8-K · Aug 16, 2024
- Conduit Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Aug 13, 2024
- Conduit Pharmaceuticals Files 10-Q for Q2 2024 — 10-Q · Aug 12, 2024
- Conduit Pharmaceuticals Inc. Files 8-K — 8-K · Aug 8, 2024
- Conduit Pharmaceuticals Inc. Files 8-K: Material Agreements & Equity Sales — 8-K · Aug 7, 2024
- Conduit Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Jul 11, 2024
- Conduit Pharmaceuticals Files 8-K on Shareholder Nominations — 8-K · Jul 1, 2024
- Conduit Pharmaceuticals Fails Listing Rule — 8-K · May 31, 2024
- Conduit Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Conduit Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 16, 2024
- Polar Asset Mgmt. Reports 1.3% Stake in Conduit Pharma — SC 13G/A · Feb 12, 2024
- Saba Capital Maintains Stake in Conduit Pharma as of Dec 31, 2023 — SC 13G/A · Feb 8, 2024
- Hudson Bay Capital Reports 9.9% Stake in Conduit Pharma — SC 13G/A · Feb 2, 2024